WallStSmart

Broadcom Inc (AVGO)vsUipath Inc (PATH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Broadcom Inc generates 4140% more annual revenue ($68.28B vs $1.61B). AVGO leads profitability with a 36.6% profit margin vs 17.5%. PATH appears more attractively valued with a PEG of 0.36. AVGO earns a higher WallStSmart Score of 78/100 (B+).

AVGO

Strong Buy

78

out of 100

Grade: B+

Growth: 9.3Profit: 9.5Value: 5.0Quality: 6.5
Piotroski: 6/9Altman Z: 1.59

PATH

Strong Buy

73

out of 100

Grade: B

Growth: 8.0Profit: 6.5Value: 8.0Quality: 7.0
Piotroski: 5/9Altman Z: 1.39
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AVGO.

PATHUndervalued (+28.0%)

Margin of Safety

+28.0%

Fair Value

$16.24

Current Price

$10.68

$5.56 discount

UndervaluedFair: $16.24Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AVGO6 strengths · Avg: 9.3/10
Market CapQuality
$1.92T10/10

Mega-cap, among the largest globally

Return on EquityProfitability
33.4%10/10

Every $100 of equity generates 33 in profit

Profit MarginProfitability
36.6%10/10

Keeps 37 of every $100 in revenue as profit

Operating MarginProfitability
44.9%10/10

Strong operational efficiency at 44.9%

PEG RatioValuation
0.878/10

Growing faster than its price suggests

Revenue GrowthGrowth
29.5%8/10

Revenue surging 29.5% year-over-year

PATH4 strengths · Avg: 9.5/10
PEG RatioValuation
0.3610/10

Growing faster than its price suggests

EPS GrowthGrowth
105.7%10/10

Earnings expanding 105.7% YoY

Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Areas to Watch

AVGO3 concerns · Avg: 2.7/10
Altman Z-ScoreHealth
1.594/10

Distress zone — elevated risk

P/E RatioValuation
79.2x2/10

Premium valuation, high expectations priced in

Price/BookValuation
24.8x2/10

Trading at 24.8x book value

PATH1 concerns · Avg: 2.0/10
Altman Z-ScoreHealth
1.392/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : AVGO

The strongest argument for AVGO centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 36.6% and operating margin at 44.9%. Revenue growth of 29.5% demonstrates continued momentum.

Bull Case : PATH

The strongest argument for PATH centers on PEG Ratio, EPS Growth, Debt/Equity. Profitability is solid with margins at 17.5% and operating margin at 16.7%. Revenue growth of 13.6% demonstrates continued momentum.

Bear Case : AVGO

The primary concerns for AVGO are Altman Z-Score, P/E Ratio, Price/Book. A P/E of 79.2x leaves little room for execution misses.

Bear Case : PATH

The primary concerns for PATH are Altman Z-Score.

Key Dynamics to Monitor

AVGO profiles as a growth stock while PATH is a mature play — different risk/reward profiles.

AVGO carries more volatility with a beta of 1.25 — expect wider price swings.

AVGO is growing revenue faster at 29.5% — sustainability is the question.

AVGO generates stronger free cash flow (8.0B), providing more financial flexibility.

Bottom Line

AVGO scores higher overall (78/100 vs 73/100), backed by strong 36.6% margins and 29.5% revenue growth. PATH offers better value entry with a 28.0% margin of safety. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Broadcom Inc

TECHNOLOGY · SEMICONDUCTORS · USA

Broadcom Inc. is an American designer, developer, manufacturer and global supplier of a wide range of semiconductor and infrastructure software products. Broadcom's product offerings serve the data center, networking, software, broadband, wireless, and storage and industrial markets.

Visit Website →

Uipath Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

UiPath Inc. provides an end-to-end automation platform offering a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company is headquartered in New York, New York.

Visit Website →

Want to dig deeper into these stocks?